Literature DB >> 26725433

Yokukansan, a Traditional Japanese Medicine, Enhances the L-DOPA-Induced Rotational Response in 6-Hydroxydopamine-Lesioned Rats: Possible Inhibition of COMT.

Yasushi Ishida1, Kosuke Ebihara, Masahiro Tabuchi, Sachiko Imamura, Kyoji Sekiguchi, Kazushige Mizoguchi, Yoshio Kase, Go Koganemaru, Hiroshi Abe, Yasushi Ikarashi.   

Abstract

The aim of the present study was to investigate the effects of the traditional Japanese medicine yokukansan (YKS) on the function of dopamine (DA) in the rat nigrostriatal system. Unilateral 6-hydroxydopamine lesions were produced in the rat nigrostriatal system. Despite a marked loss in the striatal immunoreactivity of tyrosine hydroxylase on the lesion side, striatal serotonin (5-HT) immunoreactivity was not affected. Treatment using L-3,4-dihydroxyphenylalanine (L-DOPA) in conjunction with benserazide for 15 d induced abnormal involuntary movements (AIMs) such as locomotive (rotational response), axial, forelimb, and orolingual movements in the lesioned rats. The L-DOPA-induced locomotive and axial, but not forelimb and orolingual, AIMs were significantly increased and prolonged by the pre-administration of YKS. We next investigated the effects of YKS on the production of DA from L-DOPA in 5-HT synthetic RIN 14B cells. RIN 14B cells produced DA and its metabolite, 3-methoxytyramine (3-MT), following L-DOPA treatment. YKS significantly augmented DA production and inhibited its metabolism to 3-MT in a manner similar to the catechol-O-methyltransferase (COMT) inhibitor entacapone. YKS and some alkaloids (corynoxeine: CX, geissoschizine methyl ether: GM) in Uncaria hook, a constituent herb of YKS, also inhibited COMT activity, indicating that the augmenting effect of YKS on L-DOPA-induced DA production in 5-HT synthetic cells was due to the inhibition of COMT by CX and GM. Our results suggest that YKS facilitates the DA supplemental effect of L-DOPA, and that COMT inhibition by CX and GM contributes, at least in part, to the effects of YKS.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26725433     DOI: 10.1248/bpb.b15-00691

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  The Kampo medicine Yokukansan (YKS) enhances nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells.

Authors:  Kazuki Terada; Yukari Matsushima; Kazuhisa Matsunaga; Jiro Takata; Yoshiharu Karube; Atsushi Ishige; Koji Chiba
Journal:  Bosn J Basic Med Sci       Date:  2018-08-01       Impact factor: 3.363

Review 2.  Multiple Psychopharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan, and the Brain Regions it Affects.

Authors:  Kazushige Mizoguchi; Yasushi Ikarashi
Journal:  Front Pharmacol       Date:  2017-03-21       Impact factor: 5.810

3.  Brain distribution of geissoschizine methyl ether in rats using mass spectrometry imaging analysis.

Authors:  Takashi Matsumoto; Yasushi Ikarashi; Mikina Takiyama; Junko Watanabe; Mitsutoshi Setou
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

4.  Ukgansan Protects Dopaminergic Neurons against MPTP-Induced Neurotoxicity via the Nurr1 Signaling Pathway.

Authors:  In-Cheol Chae; Jung-Hee Jang; In-Chan Seol; Yoon-Sik Kim; Gunhyuk Park; Ho-Ryong Yoo
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-20       Impact factor: 2.650

Review 5.  Properties, Pharmacology, and Pharmacokinetics of Active Indole and Oxindole Alkaloids in Uncaria Hook.

Authors:  Hirotaka Kushida; Takashi Matsumoto; Yasushi Ikarashi
Journal:  Front Pharmacol       Date:  2021-07-14       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.